GTS Securities’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
Other funds holding RYTM
BBA
GTS Securities's RYTM Position: Q3 2026 in Review
GTS Securities opened a new position in Rhythm Pharmaceuticals (RYTM) in Q3 2026: 2,203 shares worth $210K. The stake represents ﹤0.01% of the portfolio and ranks #1518 among its holdings. This is a return to the name: GTS Securities previously reported a position in RYTM as recently as Q2 2024.
GTS Securities first reported a position in RYTM in Q2 2024 and has held it in 2 quarters since. The position peaked at $950K in Q2 2024. 328 funds tracked by Wall St. Rank hold RYTM as of Q3 2026.
- GTS Securities held 2,203 shares of Rhythm Pharmaceuticals worth $210K as of Q3 2026.
- Rhythm Pharmaceuticals was a new GTS Securities position in Q3 2026.
- Rhythm Pharmaceuticals made up ﹤0.01% of GTS Securities's portfolio in Q3 2026, its #1518 holding.
- GTS Securities first reported a position in Rhythm Pharmaceuticals in Q2 2024 and has held it in 2 quarters since.
- GTS Securities's Rhythm Pharmaceuticals position peaked at $950K in Q2 2024.
- 328 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q3 2026.
Based on GTS Securities's 13F filing for Q3 2026, filed 16 Nov 2026.